EP Patent

EP1281398A1 — Dermal compositions containing coenzyme q as the active ingredient

Assigned to Kaneka Corp · Expires 2003-02-05 · 23y expired

What this patent protects

The present invention provides a composition for dermal application    which comprises, as an active ingredient, an oxidized coenzyme Q represented by the formula (1):    in which n represents an integer of 1 to 12,    and/or a reduced coenzyme Q represented by the formula (2…

USPTO Abstract

The present invention provides a composition for dermal application    which comprises, as an active ingredient, an oxidized coenzyme Q represented by the formula (1):    in which n represents an integer of 1 to 12,    and/or a reduced coenzyme Q represented by the formula (2) :    in which n represents an integer of 1 to 12, the total content of the oxidized coenzyme Q and reduced coenzyme Q being 0.01 to 99% by weight relative to the whole amount of the composition. The present invention also provides a therapeutic composition for skin diseases, a cosmetic composition, a skin health care composition and a bath salt composition, each comprising the above composition for dermal application. The present invention is further provides a method for the treatment of skin diseases    which comprises applying, to a patient suffering from a skin disease, the above-mentioned therapeutic composition for skin diseases, or    a method for the treatment of skin diseases    which comprises applying, to a patient suffering from a skin disease, the above therapeutic agent for skin diseases other than the oxidized coenzyme Q represented by the formula (1) and other than the reduced coenzyme Q represented by the formula (2) in parallel with a therapeutic composition for skin diseases.

Drugs covered by this patent

Patent Metadata

Patent number
EP1281398A1
Jurisdiction
EP
Classification
Expires
2003-02-05
Drug substance claim
No
Drug product claim
No
Assignee
Kaneka Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.